One of the main characteristics of Alzheimer’s disease (AD) development is the extracellular deposits of amyloid β (Aβ) and the increase in oxidative stress associated with Aβ toxicity; so understanding the mechanism of Nrf2 in this process could lead to a new therapeutic approach in AD [18,27]. The gene discussed is NFE2L2; the disease is Alzheimer disease.